Drug
Encapsulated Mesalamine Granules
Encapsulated Mesalamine Granules: highest development phase Phase 3, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| Encapsulated Mesalamine Granules (eMG) NCT00326209 | Phase 3 | Ulcerative Colitis |
Latest
No recent events.
Follow Encapsulated Mesalamine Granules on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.